Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-09-29
DOI
10.3389/fimmu.2015.00501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
- (2014) Kea Martin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment
- (2014) Romana Mikyšková et al. JOURNAL OF LEUKOCYTE BIOLOGY
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Microtubule-Depolymerizing Agents Used in Antibody-Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
- (2014) P. Muller et al. Cancer Immunology Research
- Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity
- (2014) Philipp Müller et al. OncoImmunology
- Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21waf1/cip1
- (2013) Wai Man Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells
- (2013) Stefanie Trojandt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy
- (2013) A. J. Litterman et al. JOURNAL OF IMMUNOLOGY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
- (2013) Laura Ridolfi et al. Journal of Translational Medicine
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- CD30-Targeted Therapy with Brentuximab Vedotin and DLI in a Patient with T-Cell Posttransplantation Lymphoma
- (2013) Sebastian Theurich et al. TRANSPLANTATION
- Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
- (2013) Kristian M. Hargadon Frontiers in Immunology
- Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
- (2012) Yoshiyuki Suzuki et al. CANCER RESEARCH
- The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation
- (2012) J. Hu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Brentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission
- (2012) Sebastian Theurich et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- Mechanisms That Regulate Peripheral Immune Responses to Control Organ-Specific Autoimmunity
- (2011) Gerard F. Hoyne Clinical & Developmental Immunology
- Two signal models in innate immunity
- (2011) Mary F. Fontana et al. IMMUNOLOGICAL REVIEWS
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- CD91-dependent programming of T-helper cell responses following heat shock protein immunization
- (2011) Sudesh Pawaria et al. Nature Communications
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
- (2010) Lukas W. Pfannenstiel et al. CELLULAR IMMUNOLOGY
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Chemotherapeutic Agents Targeting the Tubulin Cytoskeleton Modify LPS-induced Cytokine Secretion by Dendritic Cells and Increase Antigen Presentation
- (2010) Viviana Marin-Esteban et al. JOURNAL OF IMMUNOTHERAPY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
- (2009) H. Tanaka et al. CANCER RESEARCH
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Pattern recognition receptors of innate immunity and their application to tumor immunotherapy
- (2009) Tsukasa Seya et al. CANCER SCIENCE
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells
- (2009) Manfred B. Lutz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Paclitaxel and immune system
- (2009) Aqeel Javeed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
- (2009) G. V. Shurin et al. JOURNAL OF IMMUNOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Significant Impairment in Immune Recovery After Cancer Treatment
- (2009) Duck-Hee Kang et al. NURSING RESEARCH
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Memory T cells need CD28 costimulation to remember
- (2009) Alina C. Boesteanu et al. SEMINARS IN IMMUNOLOGY
- Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
- (2008) Cédric Ménard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
- (2008) Lei Zhang et al. CLINICAL IMMUNOLOGY
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
- (2008) Y. Onishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological decision-making: how does the immune system decide to mount a helper T-cell response?
- (2007) Gerard E. Kaiko et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started